NCT04743388 Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System Status UNKNOWN Phase N/A
NCT04731467 A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04720976 JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04710043 Dose Escalation Trial of BNT152+153 in Patients With Cancer Status COMPLETED Phase PHASE1
NCT04706676 Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04696848 The Efficacy and Safety of CKD516 Combined With Durvalumab in Patient Refractory Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04695327 TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy Status COMPLETED Phase PHASE1
NCT04690699 LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors Status TERMINATED Phase PHASE1/PHASE2
NCT04683939 Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04679038 A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT04678921 Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04675996 First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04673396 Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor Status UNKNOWN Phase PHASE1
NCT04672434 Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT04671901 A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Status TERMINATED Phase PHASE2
NCT04666688 LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04665388 LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers Status RECRUITING Phase N/A